Literature DB >> 4850602

Anticonvulsant properties of cannabidiol.

S A Turkanis, W Cely, D M Olsen, R Karler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4850602

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


× No keyword cloud information.
  9 in total

Review 1.  Modulation of T-type calcium channels by bioactive lipids.

Authors:  Jean Chemin; Magali Cazade; Philippe Lory
Journal:  Pflugers Arch       Date:  2014-02-16       Impact factor: 3.657

2.  Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.

Authors:  S A Turkanis; P Chiu; H K Borys; R Karler
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

3.  The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.

Authors:  K T Brady; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.

Authors:  R Karler; H K Borys; S A Turkanis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

5.  Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.

Authors:  C A Hunt; R T Jones; R I Herning; J Bachman
Journal:  J Pharmacokinet Biopharm       Date:  1981-06

6.  Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.

Authors:  S A Turkanis; R Karler
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.

Authors:  R Karler; S A Turkanis
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

Review 8.  Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Manuel Merlos; Javier Garzón-Niño
Journal:  Oncotarget       Date:  2016-08-23

9.  Cannabidiol in humans-the quest for therapeutic targets.

Authors:  Simon Zhornitsky; Stéphane Potvin
Journal:  Pharmaceuticals (Basel)       Date:  2012-05-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.